Privia Health Group (NASDAQ:PRVA) Sets New 52-Week High – Time to Buy?

Privia Health Group, Inc. (NASDAQ:PRVA) reached a new 52-week high during trading on Tuesday . The company traded as high as $23.86 and last traded at $23.83, with a volume of 876142 shares trading hands. The stock had previously closed at $22.50.

Analysts Set New Price Targets

Several research analysts have recently weighed in on PRVA shares. Needham & Company LLC assumed coverage on shares of Privia Health Group in a report on Friday, January 10th. They set a “buy” rating and a $25.00 price objective on the stock. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 price target on the stock. Stephens reissued an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Barclays increased their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, JPMorgan Chase & Co. boosted their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $24.88.

Privia Health Group Stock Up 0.8 %

The firm’s 50 day moving average is $21.46 and its two-hundred day moving average is $20.17. The stock has a market cap of $2.90 billion, a price-to-earnings ratio of 241.42, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87.

Institutional Trading of Privia Health Group

Several hedge funds have recently made changes to their positions in PRVA. FMR LLC grew its stake in Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after buying an additional 271,645 shares during the last quarter. Riverbridge Partners LLC grew its position in shares of Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after acquiring an additional 958,418 shares during the last quarter. Geode Capital Management LLC lifted its position in Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock valued at $43,986,000 after purchasing an additional 23,178 shares during the last quarter. Loomis Sayles & Co. L P boosted its stake in Privia Health Group by 55.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company’s stock valued at $27,727,000 after purchasing an additional 503,002 shares during the period. Finally, Franklin Resources Inc. boosted its stake in Privia Health Group by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,311,166 shares of the company’s stock valued at $25,633,000 after purchasing an additional 10,926 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.